- Home
- EVAX vs AWX Comparison
EVAX vs AWX Comparison
Compare EVAX & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- AWX
- Stock Information
- Founded
- EVAX 2008
- AWX 1998
- Country
- EVAX Denmark
- AWX United States
- Employees
- EVAX N/A
- AWX N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- AWX Environmental Services
- Sector
- EVAX Health Care
- AWX Utilities
- Exchange
- EVAX Nasdaq
- AWX Nasdaq
- Market Cap
- EVAX 16.3M
- AWX 13.6M
- IPO Year
- EVAX 2021
- AWX 1998
- Fundamental
- Price
- EVAX $1.49
- AWX $2.58
- Analyst Decision
- EVAX Strong Buy
- AWX
- Analyst Count
- EVAX 2
- AWX 0
- Target Price
- EVAX $10.00
- AWX N/A
- AVG Volume (30 Days)
- EVAX 76.2K
- AWX 12.1K
- Earning Date
- EVAX 05-27-2025
- AWX 05-07-2025
- Dividend Yield
- EVAX N/A
- AWX N/A
- EPS Growth
- EVAX N/A
- AWX N/A
- EPS
- EVAX N/A
- AWX 0.34
- Revenue
- EVAX $3,344,000.00
- AWX $83,795,000.00
- Revenue This Year
- EVAX $102.45
- AWX N/A
- Revenue Next Year
- EVAX $100.30
- AWX N/A
- P/E Ratio
- EVAX N/A
- AWX $7.67
- Revenue Growth
- EVAX 4480.82
- AWX 3.58
- 52 Week Low
- EVAX $1.20
- AWX $2.00
- 52 Week High
- EVAX $21.80
- AWX $3.99
- Technical
- Relative Strength Index (RSI)
- EVAX 43.19
- AWX 41.21
- Support Level
- EVAX $1.20
- AWX $2.48
- Resistance Level
- EVAX $1.46
- AWX $2.65
- Average True Range (ATR)
- EVAX 0.13
- AWX 0.14
- MACD
- EVAX 0.03
- AWX 0.02
- Stochastic Oscillator
- EVAX 59.18
- AWX 38.46
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.